As of 2025-11-04, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 54.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 52.85 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is 3.8%.
The range of the Relative Valuation is 43.40 - 62.34 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 17.0x | 16.2x |
| Forward P/E multiples | 16.1x - 21.4x | 18.6x |
| Fair Price | 43.40 - 62.34 | 54.84 |
| Upside | -17.9% - 18.0% | 3.8% |
| Date | P/E |
| 2025-10-31 | 15.65 |
| 2025-10-30 | 15.17 |
| 2025-10-29 | 15.15 |
| 2025-10-28 | 15.63 |
| 2025-10-27 | 15.39 |
| 2025-10-24 | 15.92 |
| 2025-10-23 | 15.94 |
| 2025-10-22 | 15.59 |
| 2025-10-21 | 15.72 |
| 2025-10-20 | 15.50 |
| 2025-10-17 | 15.57 |
| 2025-10-16 | 15.47 |
| 2025-10-15 | 15.51 |
| 2025-10-14 | 15.33 |
| 2025-10-13 | 15.32 |
| 2025-10-10 | 15.29 |
| 2025-10-09 | 15.73 |
| 2025-10-08 | 15.98 |
| 2025-10-07 | 15.98 |
| 2025-10-06 | 16.25 |
| 2025-10-03 | 16.19 |
| 2025-10-02 | 16.23 |
| 2025-10-01 | 16.03 |
| 2025-09-30 | 15.82 |
| 2025-09-29 | 15.78 |
| 2025-09-26 | 15.73 |
| 2025-09-25 | 15.37 |
| 2025-09-24 | 15.71 |
| 2025-09-23 | 15.60 |
| 2025-09-22 | 15.76 |
| 2025-09-19 | 15.88 |
| 2025-09-18 | 16.11 |
| 2025-09-17 | 15.88 |
| 2025-09-16 | 15.76 |
| 2025-09-15 | 15.52 |
| 2025-09-12 | 15.80 |
| 2025-09-11 | 16.33 |
| 2025-09-10 | 15.92 |
| 2025-09-09 | 16.27 |
| 2025-09-08 | 16.47 |
| 2025-09-05 | 16.88 |
| 2025-09-04 | 16.58 |
| 2025-09-03 | 17.23 |
| 2025-09-02 | 17.26 |
| 2025-08-29 | 17.02 |
| 2025-08-28 | 16.85 |
| 2025-08-27 | 17.14 |
| 2025-08-26 | 16.78 |
| 2025-08-25 | 17.09 |
| 2025-08-22 | 17.11 |